Sun Pharma reports 31 pc jump in Q1 net profit at Rs 1,387 crore

ANI
13 Aug 2019, 19:07 GMT+10

Mumbai (Maharashtra) [India], Aug 13 (ANI): Sun Pharmaceutical on Tuesday reported a net profit of Rs 1,387 crore in the April to June quarter of 2019-20, up 31 per cent in the year-on period.

The gross sales were up 16 per cent at Rs 8,259 crore. While India sales were up 8 per cent at Rs 2,314 crore, the US finished dosage sales moved up by 12 per cent to 424 million dollars.

The emerging markets sales were flat at 194 million dollars. Rest of the world sales showed a growth of 56 per cent at 167 million dollars. The company made RD investments of Rs 422 crore (5.1 per cent of sales) compared to Rs 500 crore (7 per cent of sales) in Q1 FY19.

"We have recorded growth across most of the markets for the quarter and our performance is in-line with our full-year guidance," said Managing Director Dilip Shanghvi.

"We have recorded growth across most of the markets for the quarter and our performance is in-line with our full-year guidance. We are consistently focusing on improving our efficiencies and cost structure to ensure reasonable returns for our generics business," he said in a statement.

The recent out-licensing of Tildrakizumab and Cequa for Greater China market and the regulatory filing of Tildrakizumab in Japan reflects the company's global aspirations for the specialty business. Ilumya/Ilumetri is gradually gaining traction in the United States and westernEurope, said Shanghvi.

Sun Pharma is the world's fifth largest speciality generic pharmaceutical company and India's top pharmaceutical company. It has 42 manufacturing facilities across six continents. (ANI)

Watch latest videos

News RELEASES

Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Canada Standard.

More Information

null in null

International

Section

Sources: Meta won’t alter data model, faces fresh EU charges

BRUSSELS, Belgium: Meta is holding firm on its controversial pay-or-consent model, a move that could lead to fresh antitrust charges...

Trump’s tariff push could push US rates above 20%, ICC says

LONDON, U.K.: American consumers and businesses could soon face the highest overall tariff burden in more than a century, according...

U.S. Urged to Investigate After Israeli Settlers Beat Palestinian-American to Death

The family of Sayfollah Saif Musallet, a 20-year-old American citizen who was beaten to death by Israeli settlers in the occupied West...

New Hampshire federal court ruling defies Trump’s citizenship move

CONCORD, New Hampshire: A federal judge in New Hampshire issued a crucial ruling on July 10 against President Donald Trump's executive...

Houthis attack cargo ship in Red Sea, raising maritime safety fears

DUBAI, U.A.E.: A cargo ship flagged under Liberia, known as the Eternity C, sank in the Red Sea following an attack executed by Yemen's...

Trump administration restarts Ukraine arms deliveries

WASHINGTON, D.C.: The Trump administration has started sending some weapons to Ukraine again, just a week after the Pentagon told officials...

Sports

Section